Alkem Laboratories Limited (NSE:ALKEM)
India · Delayed Price · Currency is INR 5,368.00
-81.50 (-1.50%)
Aug 14, 2026, 3:15 PM IST
Alkem Laboratories Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 641,825 | 633,575 | 583,680 | 590,890 | 406,055 | 432,909 | |
Market Cap Growth | -0.38% | 8.55% | -1.22% | 45.52% | -6.20% | 30.72% |
Enterprise Value | 626,970 | 610,260 | 555,235 | 573,042 | 400,038 | 427,311 |
Last Close Price | 5368.00 | 5289.53 | 4826.07 | 4843.12 | 3298.39 | 3469.54 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 29.75 | 27.53 | 26.95 | 32.91 | 41.26 | 26.31 |
Forward PE | 26.26 | 27.02 | 24.55 | 28.26 | 26.11 | 23.64 |
PS Ratio | 4.26 | 4.31 | 4.50 | 4.67 | 3.50 | 4.07 |
PB Ratio | 4.47 | 4.42 | 4.69 | 5.52 | 4.30 | 4.89 |
P/TBV Ratio | 4.98 | 4.91 | 5.10 | 6.01 | 4.75 | 5.30 |
P/FCF Ratio | 47.69 | 47.08 | 47.18 | 34.99 | 28.01 | 56.07 |
P/OCF Ratio | 32.70 | 32.28 | 30.51 | 30.33 | 24.13 | 38.97 |
PEG Ratio | 2.66 | 3.26 | 1.79 | 1.07 | 2.67 | 2.26 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.16 | 4.15 | 4.28 | 4.52 | 3.45 | 4.02 |
EV/EBITDA Ratio | 21.02 | 20.96 | 22.55 | 25.73 | 25.17 | 21.24 |
EV/EBIT Ratio | 23.99 | 23.46 | 25.80 | 29.13 | 30.32 | 24.51 |
EV/FCF Ratio | 46.59 | 45.35 | 44.88 | 33.93 | 27.60 | 55.34 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.14 | 0.14 | 0.11 | 0.13 | 0.15 | 0.30 |
Debt / EBITDA Ratio | 0.69 | 0.69 | 0.55 | 0.63 | 0.86 | 1.31 |
Debt / FCF Ratio | - | 1.52 | 1.12 | 0.84 | 0.96 | 3.46 |
Net Debt / Equity Ratio | -0.14 | -0.14 | -0.19 | -0.22 | 0.03 | 0.15 |
Net Debt / EBITDA Ratio | -0.69 | -0.69 | -0.97 | -1.07 | 0.16 | 0.67 |
Net Debt / FCF Ratio | - | -1.50 | -1.94 | -1.41 | 0.18 | 1.76 |
Asset Turnover | - | 0.76 | 0.78 | 0.86 | 0.83 | 0.83 |
Inventory Turnover | - | 1.69 | 1.76 | 1.92 | 1.79 | 1.61 |
Quick Ratio | - | 1.50 | 1.60 | 1.57 | 0.94 | 0.70 |
Current Ratio | - | 2.55 | 2.76 | 2.61 | 2.36 | 1.76 |
Return on Equity (ROE) | - | 17.56% | 19.14% | 17.98% | 11.01% | 20.48% |
Return on Assets (ROA) | - | 8.43% | 8.09% | 8.38% | 5.93% | 8.52% |
Return on Invested Capital (ROIC) | 16.29% | 19.06% | 20.55% | 19.55% | 10.24% | 17.85% |
Return on Capital Employed (ROCE) | - | 16.20% | 15.70% | 17.00% | 13.10% | 18.80% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 14, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 3.36% | 3.63% | 3.71% | 3.04% | 2.42% | 3.80% |
FCF Yield | 2.10% | 2.12% | 2.12% | 2.86% | 3.57% | 1.78% |
Dividend Yield | 0.99% | 1.00% | 0.93% | 0.83% | 0.76% | 0.98% |
Payout Ratio | - | 26.49% | 23.19% | 29.96% | 23.08% | 25.43% |
Total Shareholder Return | 0.99% | 1.00% | 0.93% | 0.83% | 0.76% | 0.98% |